Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07340203

Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation

The investigators will conduct a validity and reliability study of the Wexner Constipation Questionnaire, used for constipation, in Turkish. For this purpose, investigators will administer the Wexner Questionnaire, translated from English to Turkish, and the accompanying Constipation Quality of Life Scale to 200 participants. Investigators will repeat the Wexner questionnaire for some participants after two weeks.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kirşehir Ahi Evran University Physical Therapy and Rehabilitation Hospital

Kırşehir, Centre, 40000, Turkey (Türkiye)

About this study

To assess the cultural adaptation, validity, and reliability of the eight-question Wexner Constipation Questionnaire, the questionnaire was first translated from English to Turkish, then back from Turkish to English, and finally back from English to Turkish. The questionnaire was finalized with the collaboration of an internal medicine specialist and a gastroenterologist to prepare the Turkish version. It will then be administered to a minimum of 200 participants, along with the Constipation Quality of Life Questionnaire, previously validated and reliable in Turkish and used for constipation. For reliability, the questionnaire will be repeated for a portion of the participants after two weeks.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being over 18 years of age
  • Being diagnosed with functional constipation according to Rome IV criteria
  • Having undergone an anorectal examination by a gastroenterologist
  • Having no history of neurodegenerative disease (e.g., multiple sclerosis, spinal cord injury, or stroke)
  • Having no history of metabolic disorders (e.g., diabetes, hypothyroidism, or hypercalcemia)
  • Having no history of opioid-induced constipation
  • Having no history of irritable bowel syndrome
  • Having no history of congenital anorectal abnormality
  • Having no history of colon cancer or pregnancy
  • Having the ability to read and write Turkish.

Exclusion criteria

  • Not wanting to continue the study.
  • Having any complaints, such as anorectal bleeding, during the test-retest interval.

Treatment and study plan

Survey

Other

survey application

Other names: questionnaire

Primary outcomes

  1. Application of survey to participants

    Time frame: approximately 1 month

    First administration of the Wexner questionnaire to all participants

  2. Application of survey to participants

    Time frame: approximately 1 month

    First administration of the quality of life questionnaire to all participants

Secondary outcomes

  1. Application of survey to participants

    Time frame: approximately 1 week

    Wexner questionnaire were administered to the participants a second time two weeks later.

  2. Application of survey to participants

    Time frame: approximately 1 week

    Quality of life questionnaire were administered to the participants a second time two weeks later.

Sponsors and collaborators

Lead sponsor

Ahi Evran University Education and Research Hospital

Other

Registry information

Official study title

Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jan 14, 2026
Registry last updated
Jan 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.